These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Study stirs debate about statin use in those without high cholesterol. Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535 [No Abstract] [Full Text] [Related]
3. Was the FDA misled by JUPITER? MacDonald GP J Am Osteopath Assoc; 2010 Aug; 110(8):424-5. PubMed ID: 20805547 [No Abstract] [Full Text] [Related]
4. The JUPITER Trial: responding to the critics. Ridker PM; Glynn RJ Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837 [No Abstract] [Full Text] [Related]
5. The Jupiter trial--new territory for statins? Wheeler DC Nephrol Dial Transplant; 2009 Jul; 24(7):2036-7. PubMed ID: 19541666 [No Abstract] [Full Text] [Related]
7. The editor's roundtable: the JUPITER trial--initial results and clinical implications. Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439 [No Abstract] [Full Text] [Related]
8. Rosuvastatin in patients with elevated C-reactive protein. Pierard LA N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277 [No Abstract] [Full Text] [Related]
9. The numbers are in: statins for the primary prevention of cardiovascular disease in women. Duvernoy CS; Blumenthal R Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993 [No Abstract] [Full Text] [Related]
10. Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal. de Lorgeril M; Salen P; Abramson J; Dodin S; Hamazaki T; Kostucki W; Okuyama H; Pavy B; Rabaeus M Arch Intern Med; 2010 Jun; 170(12):1032-6. PubMed ID: 20585068 [TBL] [Abstract][Full Text] [Related]
12. Is Jupiter also a god of primary prevention? Accad M; Fred HL Tex Heart Inst J; 2010; 37(1):6-7. PubMed ID: 20200621 [No Abstract] [Full Text] [Related]
18. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related]
19. [JUPITER study, more reason to give statins as preventive measure - commentary]. Narkiewicz K Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067 [No Abstract] [Full Text] [Related]
20. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects]. HÃ¥kansson J Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433 [No Abstract] [Full Text] [Related] [Next] [New Search]